Tragara
Development of proprietary medicines for the treatment of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€12—18m (Dealroom.co estimates Nov 2016.)
Carlsbad California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$9.4m | Series B | ||
$3.0m | Series B | ||
| N/A | $1.2m | Debt | |
| N/A | $13.1m | Late VC | |
| N/A | $3.3m | Early VC | |
| Total Funding | €67.1m | ||
Related Content
Recent News about Tragara
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.